CD4 and myeloid sarcoma: Both CD4+ and CD8+ T cells were present in the CP of all cases, but only CD8+ T cell density was significantly higher in progressive MS patients 2.83e-5 cells/μm2) relative to controls (1.53e-5 cells/μm2; Fig. 3a and b).